Pain News and Research

Latest Pain News and Research

Kineta, RLB Holdings form joint venture to address unmet medical needs

Kineta, Inc., a biotechnology company focused on the development of immune-modulating drugs for critical diseases, and RLB Holdings, an investment fund founded by Ray and Lydia Bartoszek, have formed a joint venture, Kineta RLB, LLC, which will commercialize promising, high-value compounds in selective disease areas with unmet medical needs.

15 Apr 2014

Sanofi Korea launches gut health product, Probi Digestis

Probi has signed a distribution and supply agreement with Sanofi. Following this the Consumer Healthcare division of Sanofi Korea is making a major launch of Probi´s gut health product, Probi Digestis starting in April 2014. Probi has already delivered products and received substantial orders for the coming quarters.

15 Apr 2014

Antibiotics present a safe option for treating children with uncomplicated acute appendicitis

Using antibiotics alone to treat children with uncomplicated acute appendicitis is a reasonable alternative to surgery that leads to less pain and fewer missed school days, according to a pilot study.

15 Apr 2014

Drugs used to treat osteoporosis appear to prevent cell membrane repair

A class of drugs widely used to treat osteoporosis appears to impede a cell's ability to repair a protective outer membrane that helps determine what enters and exits, researchers report.

15 Apr 2014

Researchers find link between patient satisfaction and SDM during radiation treatment

Playing an active role in their radiation treatment decisions leaves cancer patients feeling more satisfied with their care, and may even relieve psychological distress around the experience, researchers from the Perelman School of Medicine at the University of Pennsylvania report in the journal Cancer.

15 Apr 2014

FzioMed receives FDA notification to convene usage of Oxiplex Gel

FzioMed, Inc., a medical device manufacturer specializing in biomaterials, has received notification from FDA that the Medical Device Dispute Resolution Panel (MDDRP) will convene and make a decision on the approvability of Oxiplex Gel on June 10, 2014.

11 Apr 2014

Tissue reconstruction using autologous engineered implants has been successfully achieved in humans

Reconstruction of damaged/absent tissue using engineered autologous (from the patients’ own cells) implants has been successfully achieved in humans for the first time.

11 Apr 2014

Scientists shed light on runny nose

Scientists at the University of Colorado School of Medicine have shed light on one of the most common of ailments - the runny nose.

11 Apr 2014

Scientists report first human recipients of laboratory-grown vaginal organs

Scientists reported today the first human recipients of laboratory-grown vaginal organs. A research team led by Anthony Atala, M.D., director of Wake Forest Baptist Medical Center's Institute for Regenerative Medicine, describes in the Lancet long-term success in four teenage girls who received vaginal organs that were engineered with their own cells.

11 Apr 2014

Findings pave way for potential therapy to combat H1N1 flu virus

Flu epidemics cause up to half a million deaths worldwide each year, and emerging strains continually threaten to spread to humans and cause even deadlier pandemics. A study by McGill University professor Maziar Divangahi published by Cell Press on April 10 in the journal Immunity reveals that a drug that inhibits a molecule called prostaglandin E2 (PGE2) increases survival rates in mice infected with a lethal dose of the H1N1 flu virus.

11 Apr 2014

Mayo Clinic collaborates with Enterprise Ireland to advance novel medical technologies

Mayo Clinic today announced a five-year collaboration with Enterprise Ireland, the Irish enterprise development agency, to advance novel medical technologies originating from Mayo Clinic.

11 Apr 2014

Special Hazelden Betty Ford Foundation conference to focus on issues surrounding addiction

The Hazelden Betty Ford Foundation's Professionals in Residence program in collaboration with the University of Minnesota Department of Family Medicine and Community Health and the Scaife Family Foundation will host a special conference June 20-21 in Minnesota for primary health care providers to learn more about the issues surrounding addiction.

11 Apr 2014

Researcher develops novel IBT to help opioid-dependent Vermonters

Opioid dependence - addiction to heroin and prescription painkillers - has reached epidemic levels across the country, with treatment waitlists also at an all-time high.

11 Apr 2014

RWJUH offers new alternative to open up blocked arteries

Treatment options for high-risk heart patients with severely calcified coronary artery disease (CAD) have been limited for more than 20 years. Now, Robert Wood Johnson University Hospital offers a new alternative to open up blocked arteries.

11 Apr 2014

TSRI scientists to study effects of pain medication on prenatal brain development

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded a $472,500 Cutting Edge Basic Research Award (CEBRA) by the National Institute on Drug Abuse (NIDA) of the National Institutes of Health to study models of the brain development of newborns who have been exposed-and become addicted-to prescription pain medication while still in the womb.

10 Apr 2014

Moffitt Cancer Center initiates phase I clinical trial of cancer vaccine ID-G305

Moffitt Cancer Center has initiated a phase I clinical trial for a new immunotherapy drug, ID-G305, made by Immune Design. Immunotherapy is a treatment option that uses a person's own immune system to fight cancer. It has several advantages over standard cancer therapies, including fewer side effects and an overall better tolerability. It tends to be most effective in patients who have smaller, localized tumors that have not spread to distant sites.

10 Apr 2014

2014 PAINWeekEnd Regional Conference to highlight health crises of inadequate pain management

There are 116 million people in pain. There are 4,000 pain specialists. That's 29,000 patients per pain specialist. There are simply not enough pain specialists to go around.

9 Apr 2014

Forest Laboratories, Almirall receive feedback from FDA regarding fixed dose combination of aclidinium/formoterol

Forest Laboratories, Inc. and Almirall, S.A. today announced that they have recently received feedback from the U.S. Food and Drug Administration (FDA) regarding the fixed dose combination of aclidinium and formoterol.

9 Apr 2014

FDA approves Teva Pharmaceutical's Generic Lovaza Capsules

Teva Pharmaceutical Industries Ltd. announces the approval of the generic equivalent to Lovaza® (Omega-3-Acid Ethyl Esters Capsules, USP), in the United States.

9 Apr 2014

FAST Upset Stomach offers one shot dose of Liquid Relief for people suffering from heartburn

First Aid Shot Therapy, makers of First Aid Shot Therapy Pain Relief, today announced the launch of its newest offering, First Aid Shot Therapy Upset Stomach. Upset Stomach is the second variant to be launched in the F.A.S.T. range of products and it is formulated to relive upset stomach symptoms.

9 Apr 2014

Pain News and Research

Latest Pain News and Research

Kineta, RLB Holdings form joint venture to address unmet medical needs

Sanofi Korea launches gut health product, Probi Digestis

Antibiotics present a safe option for treating children with uncomplicated acute appendicitis

Drugs used to treat osteoporosis appear to prevent cell membrane repair

Researchers find link between patient satisfaction and SDM during radiation treatment

FzioMed receives FDA notification to convene usage of Oxiplex Gel

Tissue reconstruction using autologous engineered implants has been successfully achieved in humans

Scientists shed light on runny nose

Scientists report first human recipients of laboratory-grown vaginal organs

Findings pave way for potential therapy to combat H1N1 flu virus

Mayo Clinic collaborates with Enterprise Ireland to advance novel medical technologies

Special Hazelden Betty Ford Foundation conference to focus on issues surrounding addiction

Researcher develops novel IBT to help opioid-dependent Vermonters

RWJUH offers new alternative to open up blocked arteries

TSRI scientists to study effects of pain medication on prenatal brain development

Moffitt Cancer Center initiates phase I clinical trial of cancer vaccine ID-G305

2014 PAINWeekEnd Regional Conference to highlight health crises of inadequate pain management

Forest Laboratories, Almirall receive feedback from FDA regarding fixed dose combination of aclidinium/formoterol

FDA approves Teva Pharmaceutical's Generic Lovaza Capsules

FAST Upset Stomach offers one shot dose of Liquid Relief for people suffering from heartburn

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Pain News and Research

Latest Pain News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in